Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Julia Hippisley-Cox Division of General Practice,
Nottingham University, Nottingham NG7 2RD Correspondence to: J Hippisley-Cox
julia.hippisley-cox{at}nottingham.ac.uk
Standards one to four of the national service framework for
coronary heart disease require general practitioners in England to
identify all patients with established coronary heart disease or
stroke, record their coronary risk factors, and offer appropriate treatment and to identify and treat patients at high risk of developing coronary heart disease.1 We estimated the general practice workload involved in meeting these goals.
We invited 65 practices randomly selected from the 51 primary care groups in the Trent region to participate; 24 practices volunteered and 18 were recruited.2 Ethical approval was
obtained. We identified two target groups of high risk patients aged
35-74: patients with a Read code for ischaemic heart disease or stroke or at least one prescription for a nitrate (group 1),3 and patients with a computer recorded Read code for diabetes or
hypertension (excluding those in group 1) who would be at high risk of
developing coronary heart disease (group 2).
![]()
Participants, methods, and results
Top
Participants, methods, and...
Comment
References
During March and April 2000, we extracted details of ischaemic heart disease, comorbidity (diabetes, hypertension, and stroke), drug treatment, and other coronary risk factors (age, sex, family history of cardiovascular disease, most recent smoking status, body mass index, blood pressure, glycated haemoglobin, and fasting lipid concentrations) from the practice computers. Descriptive data were analysed in SPSS (version 8) and Stata (version 5.0).
Of the 98 137 registered patients, 10 325 (10.5%) patients aged
35-74 years had at least one of ischaemic heart disease, stroke, diabetes, and hypertension. Fasting serum cholesterol concentrations had been recorded for 2267/4455 (50.9%) patients in group 1 and 2478/5870 (42.2%) in group 2. Of these, 1527/2267 (67.4%)
patients in group 1 and 1809/2478 (73.0%) in group 2 had fasting
serum cholesterol concentrations >5 mmol/l, with 1448 (63.9%)
and 400 (16.1%), respectively, taking lipid lowering agents. Of
the 1076 patients with a recorded history of myocardial infarction, 692 (64.3%) had received a
blocker. Aspirin was being taken by
3213 (72.1%) patients in group 1 and 1326 (22.6%) in group 2. Reducing the blood pressure target from 160/90 to 140/85 mm Hg (the
current recommended target4) increased the number of high
risk patients needing improved control from 2702/10325 (26.2%) to 6375 (61.7%). Of the 1839 patients with diabetes, 1518 (82.5%) had a
glycated haemoglobin value recorded on computer, and of these, 729 (48%) had a value
7.5%, which indicated moderate to poor glucose control.
The number of patients who needed risk factors recorded on computer or
further disease control measures was estimated on the basis of the
proportion of patients in the whole study population (table). Practices
varied 14-fold in recording risk factors on computer and fourfold in
the need for further disease control measures. We estimate that in the
average practice of 10 000 patients about 904 items will need
recording and about 2221 disease control measures will be needed (see table).
| |
Comment |
|---|
|
|
|---|
The national service framework for coronary heart disease has profound implications for primary care. Changes in workload and funding vary substantially between general practices.
Our estimates are conservative for a number of reasons. Practices in
the study had systems compatible with MIQUEST (a computer software
programme for data extraction) and their data might be of better
quality than those from an average practice. We looked at data recorded
on computers; examination of manual records and other information
systems might reveal higher numbers of cases and better standards of
care. We did not include patients without heart disease, diabetes, or
hypertension who may have an absolute cardiovascular risk of
3% a
year based on other risk factors. Our data included patients aged
35-74, but elderly patients have a higher cardiovascular risk and are
more likely to gain from risk factor modification.5
Substantial variations in the recording of risk factors and the need
for further disease control measures between practices were not
explained by differences in the age-sex structure of the practice
population. Some variation may be due to differences in how computer
Read codes are used.
| |
Acknowledgments |
|---|
We thank the 18 general practices that took part in the study.
| |
Footnotes |
|---|
Contributors: JHC and MP initiated and designed the study. Nicola Crown, research assistant, and Andy Meal, lecturer in nursing, wrote the MIQUEST queries and organised the data collection. JHC designed and performed the data analysis. JHC and MP interpreted the results and drafted the paper. Carol Coupland, senior lecturer in statistics, advised on statistical revisions required by the editorial board. JHC is the guarantor of the paper.
Funding: Grant from Trent NHS Executive
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Department of Health. National Service Framework for Coronary Artery Disease: Modern Standards and Service Models. London: HMSO, 2000. www.doh.gov.uk/pdfs/chdnsf.pdf (accessed 17 May 2001). |
| 2. |
Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A.
Sex inequalities in ischaemic heart disease in general practice: cross sectional survey.
BMJ
2001;
322:
832-834 |
| 3. |
Campbell N, Thain J, Deans H, Ritchie L, Rawles J.
Secondary prevention in coronary heart disease: baseline survey of provision in general practice.
BMJ
1998;
316:
1430-1434 |
| 4. |
Ramsay L, Williams B, Johnstone G, MacGregor G, Poston L, Potter J, et al.
British Hypertension Society guideline for hypertension management 1999: summary.
BMJ
1999;
319:
630-635 |
| 5. | Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ 1993; 306: 1367-1373. |
Read all Rapid Responses